The reason for this finding of no disease-free survival difference in most patients "is unclear," wrote Toon Van Gorp, MD, with Leuven Cancer Institute in Leuven, Belgium, and his fellow study authors ...

A team of researchers at the VIB-KU Leuven Center for Cancer Biology, the Netherlands Cancer Institute and Oncode Institute ...

Previous results from this trial showed longer overall survival after treatment with nivolumab plus ipilimumab or with nivolumab monotherapy than with ipilimumab monotherapy in patients with ...

Study findings were mixed regarding the postsurgical combination of Keytruda and chemotherapy with or without radiation among ...

Spread the love For many in Europe, history is a relic of the past, a subject confined to textbooks. In contrast, for those of us in West Asia—often called the “Middle East,” a term rooted in ...

in Leuven, Belgium, said in an oral presentation during the meeting. Pembrolizumab plus chemotherapy is approved as a ...

2 Department of Obstetrics & Gynaecology, University Hospital Gasthuisberg, KU Leuven, Belgium Disclosure ... of PULs by classification at 48h. Serum cancer antigen 125, creatine kinase and ...

The combination did not benefit a biomarker unselected population, but those with mismatch repair-deficient tumors had extended disease-free survival.

To help patients make important decisions regarding a specialist, Newsweek is partnering with Statista for the fifth year to ...

Tumor-Induced B Cell Changes Reveal Potential Biomarker for Treatment Response in Triple Negative Breast Cancer Sep. 12, 2024 — Researchers have discovered new insights into tumor-induced B cell ...

Smart Hospitals leverage state-of-the art technology to fundamentally rethink how care is delivered within the health system.

Cancer immunotherapy is a therapy used to treat cancer patients that involves or uses components of the immune system. Some cancer immunotherapies consist of antibodies that bind to, and inhibit ...